Indexed in Journament

The Journal of investigative dermatology

ISSN 1523-1747· EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
40.4 / 100
Journament Score
Below Average
Ranked #1,289 of 29,298 scored journals (34,012 indexed)
132 Articles
Scores higher than 95.6% of scored journals
050100
The Journament Score is computed from platform statistics — reader engagement, accessibility, publication timeliness, keyword breadth, community impact and content distribution — into a single 0–100 figure, recalculated as new articles and metadata are indexed. Dimensions that cannot be measured for this journal are excluded rather than estimated. It is independent of the paid AI Quality Analysis, which never affects this score or the ranking. Full methodology →

About This Journal

Short Name J Invest Dermatol
Abbreviated Name j invest dermatol
ISSN 1523-1747
URL https://www.sciencedirect.com/journal/journal-of-investigative-dermatology

Quality Profile

7 of 12 dimensions measured
This journal Average of scored journals
Platform statistics — the free Journament Score AI Quality Analysis — separate paid product, ranks nothing

5 of the 12 dimensions could not be measured for this journal. They are left as gaps in the shape rather than plotted as zero.

Show the numbers
Dimension This journal Corpus average
Engagement 30.7 30.4
Accessibility 20.0 22.5
Timeliness 0.0 3.0
Diversity 61.1 22.7
Innovation 70.0 24.1
Community Impact 13.6 4.2
Content Distribution 78.0 88.7
Content Quality — 55.5
Ethics & Transparency — 40.2
Editorial Standards — 33.4
Publication Regularity — 53.2
Geographic Reach — 30.8

Publications Per Year

Articles (132)

2012
automated quantitative analysis of p53, cyclin d1, ki67 and perk expression in breast carcinoma does not differ from expert pathologist scoring and correlates with clinico-pathological characteristics
;Yolanda Madarnas;Sandip K. SenGupta;Bruce E. Elliott;Jeremy Squire;Leda H. Raptis;Ashish B. Rajput;Andrew G. Day;Waheed Sangrar;Sonal Varma;Jamaica D. Cass
Vol. 4 , No. 3 , pp. 725-742
460 views DOI Abstract
2018
targeting pancreatic cancer cell plasticity: the latest in therapeutics
;Jacob M. Smigiel;Neetha Parameswaran;Mark W. Jackson
Vol. 10 , No. 1 , pp. 14-
451 views DOI Abstract
2018
towards a clinical decision support system for external beam radiation oncology prostate cancer patients: proton vs. photon radiotherapy? a radiobiological study of robustness and stability
;Seán Walsh;Erik Roelofs;Peter Kuess;Yvonka van Wijk;Ben Vanneste;Andre Dekker;Philippe Lambin;Bleddyn Jones;Dietmar Georg;Frank Verhaegen
Vol. 10 , No. 2 , pp. 55-
448 views DOI Abstract
2015
the hedgehog signalling pathway in cell migration and guidance: what we have learned from drosophila melanogaster
;Sofia J. Araújo
Vol. 7 , No. 4 , pp. 2012-2022
427 views DOI Abstract
2011
gold nanostructures as a platform for combinational therapy in future cancer therapeutics
;Salomeh Jelveh;Devika B. Chithrani
Vol. 3 , No. 1 , pp. 1081-1110
414 views DOI Abstract
2013
immune-checkpoint blockade and active immunotherapy for glioma
;Brian J. Ahn;Ian F. Pollack;Hideho Okada
Vol. 5 , No. 4 , pp. 1379-1412
411 views DOI Abstract
2018
pharmacokinetics of sublingually delivered fentanyl in head and neck cancer patients treated with curatively aimed chemo or bioradiotherapy
;Evelien J. M. Kuip;Wendy H. Oldenmenger;Esther Oomen-de Hoop;Gerda M. Verduijn;Martine F. Thijs-Visser;Peter de Bruijn;Esther van Meerten;Stijn L. W. Koolen;Ron H. J. Mathijssen;Carin C. D. van der Rijt
Vol. 10 , No. 11 , pp. 445-
406 views DOI Abstract
2018
signal-targeted therapies and resistance mechanisms in pancreatic cancer: future developments reside in proteomics
;Célia Cintas;Thibaut Douché;Nicole Therville;Silvia Arcucci;Fernanda Ramos-Delgado;Céline Basset;Benoît Thibault;Julie Guillermet-Guibert
Vol. 10 , No. 6 , pp. 174-
387 views DOI Abstract
1998
A novel human type II cytokeratin, K6hf, specifically expressed in the companion layer of the hair follicle
Winter H;Langbein L;Praetzel S;Jacobs M;Rogers MA;Leigh IM;Tidman N;Schweizer J;;
Vol. 111 , No. 6 , pp. -
380 views Abstract
2020
pembrolizumab activity in recurrent high-grade gliomas with partial or complete loss of mismatch repair protein expression: a monocentric, observational and prospective pilot study
;Giuseppe Lombardi;Valeria Barresi;Stefano Indraccolo;Michele Simbolo;Matteo Fassan;Susanna Mandruzzato;Matteo Simonelli;Mario Caccese;Marco Pizzi;Arianna Fassina;Marta Padovan;Elena Masetto;Marina Paola Gardiman;Maria Giuseppina Bonavina;Maria Caffo;Pasquale Persico;Franco Chioffi;Luca Denaro;Angelo Paolo Dei Tos;Aldo Scarpa;Vittorina Zagonel
Vol. 12 , No. 2283 , pp. 2283-
373 views DOI Abstract
2020
Multiclass artificial intelligence in dermatology - progress but still room for improvement.
Navarrete-Dechent, Cristian;Liopyris, Konstantinos;Marchetti, Michael A;
274 views DOI
2020
herc ubiquitin ligases in cancer
;Joan Sala-Gaston;Arturo Martinez-Martinez;Leonardo Pedrazza;L. Francisco Lorenzo-Martín;Rubén Caloto;Xosé R. Bustelo;Francesc Ventura;Jose Luis Rosa
Vol. 12 , No. 1653 , pp. 1653-
310 views DOI Abstract
2020
the non-coding rna landscape of plasma cell dyscrasias
;Eugenio Morelli;Annamaria Gullà;Roberta Rocca;Cinzia Federico;Lavinia Raimondi;Stefano Malvestiti;Valter Agosti;Marco Rossi;Giosuè Costa;Gianluca Giavaresi;Abdel Kareem Azab;Antonia Cagnetta;Michele Cea;Pierosandro Tagliaferri;Antonino Neri;Nikhil C. Munshi;Giuseppe Viglietto;Pierfrancesco Tassone;Nicola Amodio
Vol. 12 , No. 2 , pp. 320-
321 views DOI Abstract
2020
phenethyl isothiocyanate suppresses stemness in the chemo- and radio-resistant triple-negative breast cancer cell line mda-mb-231/ir via downregulation of metadherin
;Yen Thi-Kim Nguyen;Jeong Yong Moon;Meran Keshawa Ediriweera;Somi Kim Cho
Vol. 12 , No. 2 , pp. 268-
325 views DOI Abstract
2020
solving the time- and frequency-multiplexed problem of constrained radiofrequency induced hyperthermia
;Andre Kuehne;Eva Oberacker;Helmar Waiczies;Thoralf Niendorf
Vol. 12 , No. 1072 , pp. 1072-
254 views DOI Abstract
2020
the rna-binding ubiquitin ligase mex3a affects glioblastoma tumorigenesis by inducing ubiquitylation and degradation of rig-i
;Francesca Bufalieri;Miriam Caimano;Ludovica Lospinoso Severini;Irene Basili;Francesco Paglia;Luigi Sampirisi;Elena Loricchio;Marialaura Petroni;Gianluca Canettieri;Antonio Santoro;Luca D’Angelo;Paola Infante;Lucia Di Marcotullio
Vol. 12 , No. 2 , pp. 321-
299 views DOI Abstract
2020
identification of two kinase inhibitors with synergistic toxicity with low-dose hydrogen peroxide in colorectal cancer cells in vitro
;Eric Freund;Kim-Rouven Liedtke;Lea Miebach;Kristian Wende;Amanda Heidecke;Nagendra Kumar Kaushik;Eun Ha Choi;Lars-Ivo Partecke;Sander Bekeschus
Vol. 12 , No. 1 , pp. 122-
278 views DOI Abstract
2020
pembrolizumab activity in recurrent high-grade gliomas with partial or complete loss of mismatch repair protein expression: a monocentric, observational and prospective pilot study
;Giuseppe Lombardi;Valeria Barresi;Stefano Indraccolo;Michele Simbolo;Matteo Fassan;Susanna Mandruzzato;Matteo Simonelli;Mario Caccese;Marco Pizzi;Arianna Fassina;Marta Padovan;Elena Masetto;Marina Paola Gardiman;Maria Giuseppina Bonavina;Maria Caffo;Pasquale Persico;Franco Chioffi;Luca Denaro;Angelo Paolo Dei Tos;Aldo Scarpa;Vittorina Zagonel
Vol. 12 , No. 2283 , pp. 2283-
373 views DOI Abstract
2020
overcoming heterogeneity of antigen expression for effective car t cell targeting of cancers
;Sareetha Kailayangiri;Bianca Altvater;Malena Wiebel;Silke Jamitzky;Claudia Rossig
Vol. 12 , No. 1075 , pp. 1075-
159 views DOI Abstract
2020
erratum: benelli, r., et al. aspartate-β-hydroxylase: a promising target to limit the local invasiveness of colorectal cancer. <i>cancers</i> <b>2020</b>, <i>12</i>, 971
;Roberto Benelli;Delfina Costa;Luca Mastracci;Federica Grillo;Mark Jon Olsen;Paola Barboro;Alessandro Poggi;Nicoletta Ferrari
Vol. 12 , No. 1226 , pp. 1226-
172 views DOI Abstract
Journament Score
40.4/100 · Below Average
Ranked #1,289 of 29,298 scored
(34,012 journals indexed)
Platform Statistics
AI Quality Analysis
Separate paid analysis — does not affect ranking.
Journament

Overall Quality Score

40.4/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.7/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

20.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

61.1/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

70.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

13.6/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

0.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Content Distribution

78.0/100

Measures how evenly reader attention spreads across the journal's articles, using the Gini coefficient of article clicks.

Higher scores mean readership is distributed across many articles rather than concentrated on one or two.

Ethics & Transparency Score

Not yet measured

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

Not yet measured

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

Not yet measured

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

Not yet measured

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

Not yet measured

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.